STOP-AMDR

In Nigeria, STOP-AMDR is piloting the simultaneous use of three artemisinin-based combination therapies across six districts in Kwara and Enugu states. Treatments are assigned by age group, helping diversify malaria treatment while generating evidence on feasibility, acceptance, cost, and resistance.






